The EMT spectrum and therapeutic opportunities

Carcinomas are phenotypically arrayed along an epithelial–mesenchymal transition (EMT) spectrum, a developmental program currently exploited to understand the acquisition of drug resistance through a re‐routing of growth factor signaling. This review collates the current approaches employed in developing therapeutics against cancer‐associated EMT, and provides an assessment of their respective strengths and drawbacks. We reflect on the close relationship between EMT and chemoresistance against current targeted therapeutics, with a special focus on the epigenetic mechanisms that link these processes. This prompts the hypothesis that carcinoma‐associated EMT shares a common epigenetic pathway to cellular plasticity as somatic cell reprogramming during tissue repair and regeneration. Indeed, their striking resemblance suggests that EMT in carcinoma is a pathological adaptation of an intrinsic program of cellular plasticity that is crucial to tissue homeostasis. We thus propose a revised approach that targets the epigenetic mechanisms underlying pathogenic EMT to arrest cellular plasticity regardless of upstream cancer‐driving mutations.

• Publication year

  2017

• Venue

  Molecular Oncology

• Publication date

  2017-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1878-0261.12082PMID 28544151PMCID 5496500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

  2017cited by this paper
• The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition.

  2017cited by this paper
• SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer

  2017cited by this paper
• Lineage Tracing of Mammary Stem and Progenitor Cells.

  2017cited by this paper
• Multimodal HDAC Inhibitors with Improved Anticancer Activity.

  2017cited by this paper
• Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells

  2017influential reference
• Salinomycin kills cancer stem cells by sequestering iron in lysosomes

  2017cited by this paper
• TET1 promotes cisplatin‐resistance via demethylating the vimentin promoter in ovarian cancer

  2017cited by this paper
• Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity

  2016cited by this paper
• Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

  2016cited by this paper
• Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer

  2016cited by this paper
• The rationale for targeting TGF‐β in chronic liver diseases

  2016cited by this paper
• A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.

  2016cited by this paper
• Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

  2016influential reference
• The complexities and caveats of lineage tracing in the mammary gland

  2016cited by this paper
• Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters.

  2016cited by this paper
• EMT: 2016.

  2016cited by this paper
• The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer

  2016cited by this paper
• Twist1 Promotes Breast Cancer Invasion and Metastasis by Silencing Foxa1 Expression

  2016cited by this paper
• Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.

  2016cited by this paper
• Molecular features of cellular reprogramming and development

  2016cited by this paper
• A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer

  2016cited by this paper
• A combinatorial strategy for treating KRAS mutant lung cancer

  2016cited by this paper
• An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers

  2016cited by this paper
• A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)

  2016cited by this paper
• GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification

  2016cited by this paper
• Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling

  2015cited by this paper
• ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

  2015cited by this paper
• Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma

  2015cited by this paper
• LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition

  2015cited by this paper
• Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy

  2015influential reference
• Micropillar arrays as potential drug screens: Inhibition of micropillar-mediated activation of the FAK-Src-paxillin signaling pathway by the CK2 inhibitor CX-4945.

  2015cited by this paper
• Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

  2015cited by this paper
• Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

  2015cited by this paper
• Fibrosis Progression According to Epithelial‐Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA

  2015cited by this paper
• Valproic acid (VPA) inhibits the epithelial–mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4

  2015cited by this paper
• MicroRNA‐125b attenuates epithelial‐mesenchymal transitions and targets stem‐like liver cancer cells through small mothers against decapentaplegic 2 and 4

  2015cited by this paper
• Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

  2015cited by this paper
• Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells

  2015cited by this paper
• Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer

  2015cited by this paper
• EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer

  2015cited by this paper
• EMT is not required for lung metastasis but contributes to chemoresistance

  2015cited by this paper
• SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma

  2015cited by this paper
• Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency

  2015cited by this paper
• EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis

  2014cited by this paper
• Bright/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog

  2014cited by this paper
• Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.

  2014cited by this paper
• Combinatorial Modulation of Signaling Pathways Reveals Cell-Type-Specific Requirements for Highly Efficient and Synchronous iPSC Reprogramming

  2014influential reference
• TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator

  2014cited by this paper
• Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming.

  2014cited by this paper
• KRAS and YAP1 converge to regulate EMT and tumor survival.

  2014cited by this paper
• Systematic identification of barriers to human iPSC generation.

  2014influential reference
• TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.

  2014cited by this paper
• Axl Kinase as a Key Target for Oncology: Focus on Small Molecule Inhibitors

  2014cited by this paper
• Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer

  2014cited by this paper
• MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner

  2014cited by this paper
• MTA family of proteins in DNA damage response: mechanistic insights and potential applications

  2014cited by this paper
• High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma.

  2013cited by this paper
• HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis

  2013cited by this paper
• MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

  2013influential reference
• Screening therapeutic EMT blocking agents in a three-dimensional microenvironment.

  2013cited by this paper
• Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles

  2013cited by this paper
• MicroRNA‐216a/217‐induced epithelial‐mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

  2013cited by this paper
• An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)

  2013cited by this paper
• Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

  2013cited by this paper
• CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells

  2013cited by this paper
• The epigenetics of epithelial-mesenchymal plasticity in cancer

  2013cited by this paper
• The Invasion Inhibitor Sarasinoside A1 Reverses Mesenchymal Tumor Transformation in an E-Cadherin–Independent Manner

  2013cited by this paper
• Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013cited by this paper
• Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells

  2013influential reference
• Vitamin C modulates TET1 function during somatic cell reprogramming

  2013cited by this paper
• Stage-specific regulation of reprogramming to induced pluripotent stem cells by Wnt signaling and T cell factor proteins.

  2013cited by this paper
• Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer

  2012cited by this paper
• Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.

  2012cited by this paper
• Runx3 Protects Gastric Epithelial Cells Against Epithelial‐Mesenchymal Transition‐Induced Cellular Plasticity and Tumorigenicity

  2012cited by this paper
• Dll1+ secretory progenitor cells revert to stem cells upon crypt damage

  2012cited by this paper
• Slug and Sox9 cooperatively determine the mammary stem cell state.

  2012cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors.

  2012cited by this paper
• A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma

  2012cited by this paper
• An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

  2012influential reference
• Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

  2012cited by this paper
• Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like Cells

  2012cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012cited by this paper
• Integration of ERα-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer

  2012cited by this paper
• EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.

  2011cited by this paper
• Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.

  2011cited by this paper
• Current status of SRC inhibitors in solid tumor malignancies.

  2011cited by this paper
• EW‐7203, a novel small molecule inhibitor of transforming growth factor‐β (TGF‐β) type I receptor/activin receptor‐like kinase‐5, blocks TGF‐β1‐mediated epithelial‐to‐mesenchymal transition in mammary epithelial cells

  2011cited by this paper
• p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2

  2011cited by this paper
• Protein kinase CK2α is overexpressed in colorectal cancer and modulates cell proliferation and invasion via regulating EMT-related genes

  2011cited by this paper
• p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

  2011cited by this paper
• Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition

  2011cited by this paper
• Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells

  2011cited by this paper
• HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT

  2011cited by this paper
• The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis

  2011cited by this paper
• Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.

  2011cited by this paper
• The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1

  2010cited by this paper
• Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non–Small Cell Lung Cancer

  2010cited by this paper

• Grhl3 Coordinates Epithelial Gene Activation and Epigenetic Remodeling in Fibroblasts.

  2026cites this paper
• Modeling ncRNA-Mediated Circuits in Cell Fate Decision: From Systems Biology to Synthetic Biology.

  2025cites this paper
• The regulatory network of epithelial-mesenchymal transition-associated non-coding RNAs in thyroid cancer: molecular mechanisms, clinical implications, and therapeutic strategies

  2025cites this paper
• ER Stress Is Associated with a “Mesenchymal Drift” in an Anaplastic Thyroid Carcinoma Cell Line

  2025cites this paper
• Lycium barbarum polysaccharide suppresses uridine induced malignant progression of lung adenocarcinoma via UPP1 regulation

  2025cites this paper
• Childhood trauma is associated with theory of mind deficits in obsessive-compulsive disorder

  2025cites this paper
• Twenty Years of Epithelial-Mesenchymal Transition: A State of the Field from TEMTIA X

  2024cites this paper
• CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway

  2024cites this paper
• Revealing a Heterozygous FCGR1A Variant in a Patient with Uveal Melanoma and Von Hippel–Lindau Syndrome: A Rare Case Report

  2024cites this paper
• Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation

  2024cites this paper
• Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer

  2024cites this paper
• Cellular geometry and epithelial-mesenchymal plasticity intersect with PIEZO1 in breast cancer cells

  2024cites this paper
• Pharmacological targeting of netrin-1 inhibits EMT in cancer

  2023cites this paper
• SLUG and SNAIL as Potential Immunohistochemical Biomarkers for Renal Cancer Staging and Survival

  2023cites this paper
• Antimetastatic Activity of Apoptolidin A by Upregulation of N-Myc Downstream-Regulated Gene 1 Expression in Human Colorectal Cancer Cells

  2023cites this paper
• Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies

  2023influential citation
• Influence of C60 Nanofilm on the Expression of Selected Markers of Mesenchymal–Epithelial Transition in Hepatocellular Carcinoma

  2023cites this paper
• Finding the junction between claudins and endometrial carcinoma.

  2023cites this paper
• Expanding the ubiquitin code in pancreatic cancer.

  2023cites this paper
• Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated “Omics” Approaches to Explore Measurable Metrics

  2023cites this paper
• EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures

  2022cites this paper
• Integrin Beta 4E Promotes Endothelial Phenotypic Changes and Attenuates Lung Endothelial Cell Inflammatory Responses

  2022cites this paper
• Expression, Localization and Prognosis Association of MEP50 in Breast Cancer

  2022cites this paper
• EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients

  2022cites this paper
• Identification of hub genes associated with EMT-induced chemoresistance in breast cancer using integrated bioinformatics analysis.

  2021cites this paper
• Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers

  2021cites this paper
• Bone morphogenetic protein induces bone invasion of melanoma by epithelial–mesenchymal transition via the Smad1/5 signaling pathway

  2021cites this paper
• Punicalagin in Cancer Prevention—Via Signaling Pathways Targeting

  2021cites this paper
• SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival

  2021cites this paper
• Natural Compound Shikonin Induces Apoptosis and Attenuates Epithelial to Mesenchymal Transition in Radiation-Resistant Human Colon Cancer Cells

  2021cites this paper
• TACC3 Promotes Gastric Carcinogenesis by Promoting Epithelial-mesenchymal Transition Through the ERK/Akt/cyclin D1 Signaling Pathway

  2021cites this paper
• N‐arachidonoyl dopamine inhibits epithelial–mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol

  2021cites this paper
• The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

  2021cites this paper
• Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer

  2021cites this paper
• Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition

  2021cites this paper
• MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors

  2021cites this paper
• Inhibition of the proliferation, invasion, migration, and epithelial-mesenchymal transition of prostate cancer cells through the action of ATP1A2 on the TGF-β/Smad pathway

  2021cites this paper
• Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas

  2021cites this paper
• MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.

  2021cites this paper
• EMT, MET, Plasticity, and Tumor Metastasis.

  2020cites this paper
• Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition

  2020cites this paper
• AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells

  2020cites this paper
• Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis

  2020cites this paper
• TGFβ mediated LINC00273 upregulation sponges mir200a‐3p and promotes invasion and metastasis by activating ZEB1

  2020cites this paper
• miR-210-5p promotes epithelial–mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells

  2020cites this paper
• DMT1 Inhibitors Kill Cancer Stem Cells by Blocking Lysosomal Iron Translocation.

  2020cites this paper
• Cellular rewiring in lethal prostate cancer: the architect of drug resistance

  2020cites this paper
• Computational models to explore the complexity of the epithelial to mesenchymal transition in cancer

  2020cites this paper
• Approaching Complex Diseases: Network-Based Pharmacology and Systems Approach in Bio-Medicine

  2020cites this paper
• Tumor Plasticity and Resistance to Immunotherapy.

  2020cites this paper
• Histone deacetylase 1 and 2 drive differentiation and fusion of progenitor cells in human placental trophoblasts

  2020cites this paper
• Critical Steps in Epithelial-Mesenchymal Transition as Target for Cancer Treatment

  2020cites this paper
• Differentiation of Cancer Stem Cells by Using Synthetic Small Molecules: Toward New Therapeutic Strategies against Therapy Resistance

  2020cites this paper
• Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway

  2020cites this paper
• Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3.

  2020cites this paper
• Salvianolic acid B suppresses EMT and apoptosis to lessen drug resistance through AKT/mTOR in gastric cancer cells

  2020cites this paper
• EMT, cancer stem cells and autophagy; The three main axes of metastasis.

  2020cites this paper
• Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer

  2020cites this paper
• S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine.

  2020cites this paper
• Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties

  2020cites this paper
• Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line

  2019cites this paper
• Modeling ncRNA-Mediated Circuits in Cell Fate Decision.

  2019cites this paper
• Liquid biopsies

  2019cites this paper
• Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells.

  2019cites this paper
• OTT_A_208738 5713..5728

  2019cites this paper
• Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer

  2019cites this paper
• Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers

  2019cites this paper
• Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer

  2019cites this paper
• Hydrogen peroxide-producing NADPH oxidases and the promotion of migratory phenotypes in cancer.

  2019cites this paper
• Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon–Intron Split Analysis (EISA)

  2019cites this paper
• Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition

  2019cites this paper
• STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo

  2019influential citation
• KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.

  2019cites this paper
• Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab

  2019cites this paper
• Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance

  2019cites this paper
• Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma

  2019cites this paper
• The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

  2019cites this paper
• Regulation of miRNAs by Snail during epithelial-to-mesenchymal transition in HT29 colon cancer cells

  2019cites this paper
• Face morphogenesis is promoted by Pbx-dependent EMT via regulation of Snail1 during frontonasal prominence fusion

  2018cites this paper
• Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.

  2018cites this paper
• The role of POPX2 in the regulation of hippo pathway

  2018cites this paper
• The Pathogenesis of Intraabdominal Adhesions: Similarities and Differences to Luminal Fibrosis

  2018cites this paper
• Epigenetically distinct sister chromatids and asymmetric generation of tumor initiating cells

  2018cites this paper
• AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking

  2018cites this paper
• Fibrostenotic Inflammatory Bowel Disease

  2018cites this paper
• 11th International Symposium on Minimal Residual Cancer (ISMRC): 3–5 May 2018, Montpellier, France

  2018cites this paper
• The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells

  2018cites this paper
• miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer

  2018cites this paper
• EMT, inflammation and metastasis.

  2017cites this paper
• MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma.

  2017cites this paper
• MTA1 expression in human cancers - Clinical and pharmacological significance.

  2017cites this paper
• A Rational Drug Combination Design to Inhibit Epithelial-Mesenchymal Transition in a Three-Dimensional Microenvironment

  2017cites this paper
• Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms

  2017cites this paper